BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6453644)

  • 1. Pulmonary disease as a complication of chlorozotocin chemotherapy.
    Ahlgren JD; Smith FP; Kerwin DM; Sikic BI; Weiner JH; Schein PS
    Cancer Treat Rep; 1981; 65(3-4):223-9. PubMed ID: 6453644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorozotocin (DCNU)--induced pulmonary toxicity.
    Sordillo EM; Sordillo PP; Stover D; Magill GB
    Cancer Clin Trials; 1981; 4(4):397-9. PubMed ID: 6459189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
    Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
    Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open lung biopsy in immunocompromised patients.
    Cockerill FR; Wilson WR; Carpenter HA; Smith TF; Rosenow EC
    Arch Intern Med; 1985 Aug; 145(8):1398-404. PubMed ID: 2411238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestatic jaundice associated with chlorozotocin.
    Belt RJ; McGregor D; Haas CD; Bhatia PS
    Cancer Treat Rep; 1980; 64(12):1235-9. PubMed ID: 6451288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thoracoscopic biopsy of pulmonary lesions in nonpulmonary malignancy following chemotherapy].
    Zamir O; Ben-Arush MW; Seror D; Freund HR
    Harefuah; 1997 Sep; 133(5-6):174-6, 246. PubMed ID: 9461681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group study.
    Haas CD; McCracken JD; Vaughn CB; Stephens RL; Bukowski RM; Eyre HJ
    Invest New Drugs; 1984; 2(4):401-4. PubMed ID: 6239836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary toxicity of drugs and thoracic irradiation in children].
    Fauroux B; Clément A; Tournier G
    Rev Mal Respir; 1996 Jul; 13(3):235-42. PubMed ID: 8765915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy pneumonitis: a case report of possible synergistic toxicity.
    Goedert JJ; Smith FP; Tsou E; Weiss RB
    Med Pediatr Oncol; 1983; 11(2):116-8. PubMed ID: 6220198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation.
    Mark EJ; Ruangchira-urai R
    Ann Diagn Pathol; 2008 Jun; 12(3):171-80. PubMed ID: 18486892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of chlorozotocin: attempted amelioration of myelotoxicity by glucose administration.
    Panasci L; Comis R; Ginsberg S; Kohn L; Fitzpatrick A; Rubert M; Scalzo T
    Cancer Treat Rep; 1981; 65(7-8):647-50. PubMed ID: 6454483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
    Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I evaluation of chlorozotocin: single dose every six weeks.
    Taylor S; Belt RJ; Haas CD; Stephens RL; Hoogstraten B
    Cancer; 1980 Dec; 46(11):2365-8. PubMed ID: 6449279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer.
    Talley RW; Samson MK; Brownlee RW; Samhouri AM; Fraile RJ; Baker LH
    Eur J Cancer (1965); 1981 Mar; 17(3):337-43. PubMed ID: 6455296
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I evaluation of chlorozotocin (NSC-178248): weekly schedule.
    Moriconi WJ; Taylor S; Slavik M; Belt RJ; Haas CD; Hoogstraten B
    Invest New Drugs; 1985; 3(1):57-62. PubMed ID: 3157661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung biopsies with light microscopic and ultrastructural observations in 34 cases of diffuse pulmonary diseases].
    Wan HY; Deng WW; Zhu QR
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):18-20, 61. PubMed ID: 8082212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation].
    Ishioka S
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():432-8. PubMed ID: 9369919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise testing in interstitial lung disease.
    Kelley MA; Daniele RP
    Clin Chest Med; 1984 Mar; 5(1):145-56. PubMed ID: 6723237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus and pulmonary hypertension.
    Scherak O; Kolarz G
    Z Rheumatol; 1981; 40(3):131-4. PubMed ID: 7282111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical investigation of application of lung biopsy in the diagnosis of diffuse pulmonary interstitial disease].
    Gao ZC; Ma MX; Gu LX; Liu J; Wang J; Shen DH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Oct; 16(10):615-7. PubMed ID: 15461843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.